From a public health perspective, radon exposure concerns human inhalation of radon gas and its decay products within enclosed spaces. This exposure results in ionizing radiation affecting the pulmonary tract and increases the risk of lung cancer, making radon the second leading cause of this disease after smoking. The initial evidence emerged from studies on underground miners, revealing a dose-response relationship between radon exposure and lung cancer. Miner studies were followed by population-based case-control studies where radon was measured in dwellings. Among them, the European case-control pooling study confirmed that even low radon exposures may cause lung cancer. Every increase of 100 Bq/m3 in radon concentration at home increases 16% lung cancer risk, prompting WHO’s indication to not exceed 100 Bq/m3 in homes or workplaces. Furthermore, radon exposure and smoking have a synergic effect on lung cancer risk, and most radon-induced mortality occurs among smokers. Finally, despite the exceptionally large and conclusive evidence on the effects of radon exposure on lung cancer risk, the underlying molecular mechanisms involved remain a subject of ongoing research.